NCT01440257View on ClinicalTrials.gov

A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

September 30, 2013

Conditions
Diabetic NephropathyType 2 Diabetes Mellitus
Interventions
DRUG

Placebo

Placebo capsules once daily

DRUG

CCX140-B

CCX140-B capsules once daily (Group B)

Trial Locations (1)

Unknown

Centre for Human Drug Research, Leiden

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01440257 - A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria | Biotech Hunter | Biotech Hunter